IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel
FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed
Letter to the Editor: A Victory for Research, But Real Work Is Ahead
Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research
Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects
Funding Opportunities: RFA Available: Teams For Molecular Target Assessment
In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV
- “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor
